Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 951 JPY -1.86% Market Closed
Market Cap: 26.7B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharma Foods International Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Income from Continuing Operations
ÂĄ3.2B
CAGR 3-Years
-6%
CAGR 5-Years
45%
CAGR 10-Years
80%
GNI Group Ltd
TSE:2160
Income from Continuing Operations
ÂĄ5.4B
CAGR 3-Years
51%
CAGR 5-Years
51%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Income from Continuing Operations
ÂĄ17.1B
CAGR 3-Years
40%
CAGR 5-Years
46%
CAGR 10-Years
64%
Takara Bio Inc
TSE:4974
Income from Continuing Operations
ÂĄ145m
CAGR 3-Years
-79%
CAGR 5-Years
-49%
CAGR 10-Years
-22%
S
StemRIM Inc
TSE:4599
Income from Continuing Operations
-ÂĄ2B
CAGR 3-Years
-51%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Income from Continuing Operations
-ÂĄ632.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
26.7B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 625.98 JPY
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
3.2B JPY

Based on the financial report for Jul 31, 2024, Pharma Foods International Co Ltd's Income from Continuing Operations amounts to 3.2B JPY.

What is Pharma Foods International Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
80%

Over the last year, the Income from Continuing Operations growth was 4%. The average annual Income from Continuing Operations growth rates for Pharma Foods International Co Ltd have been -6% over the past three years , 45% over the past five years , and 80% over the past ten years .

Back to Top